It has been shown that when aggregated tau, another protein implicated in AD pathology, comes into contact with astrocytes, it induces reactive astrogliosis, leading to their transformation into the A1 phenotype and the upregulation of GFAP and vimentin [37]. Here, MAPT is linked to Alzheimer disease.